Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
Your view on RCDTF
Overview
What the company does, where it operates, and who runs it.
About Recordati Industria Chimica e Farmaceutica S.p.A.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Robert Koremans
- Headquarters
- 1, Via Matteo Civitali, Milan, MI, IT
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Robert Koremans
- Headquarters
- 1, Via Matteo Civitali, Milan, MI, IT
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide.
The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat.
It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Recordati Industria Chimica e Farmaceutica S.p.A., and the rating behind it. RCDTF last traded at $56.95, 21.4× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Recordati Industria Chimica e Farmaceutica S.p.A.. Starting points for Recordati Industria Chimica e Farmaceutica S.p.A.: P/E 21.4, EPS $2.44, beta 0.61 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Recordati Industria Chimica e Farmaceutica S.p.A.. Recordati Industria Chimica e Farmaceutica S.p.A. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Recordati Industria Chimica e Farmaceutica S.p.A.. Trailing twelve-month EPS for Recordati Industria Chimica e Farmaceutica S.p.A. stands at $2.44. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Recordati Industria Chimica e Farmaceutica S.p.A.. Recordati Industria Chimica e Farmaceutica S.p.A. has reported as a listed company since 2010. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Recordati Industria Chimica e Farmaceutica S.p.A. valued side by side against its closest peers. Recordati Industria Chimica e Farmaceutica S.p.A. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Recordati Industria Chimica e Farmaceutica S.p.A., and how their positions are changing. At a $11.62B market value, institutional positions materially move Recordati Industria Chimica e Farmaceutica S.p.A.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Recordati Industria Chimica e Farmaceutica S.p.A. executives and directors. Shares of Recordati Industria Chimica e Farmaceutica S.p.A. have traded between $49.00 and $65.44 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Recordati Industria Chimica e Farmaceutica S.p.A.. Recordati Industria Chimica e Farmaceutica S.p.A. is a $11.62B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Recordati Industria Chimica e Farmaceutica S.p.A.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Recordati Industria Chimica e Farmaceutica S.p.A.. Coverage tracks Recordati Industria Chimica e Farmaceutica S.p.A. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.